Effects of Perioperative Synbiotic Treatment on Infectious Complications,Intestinal Integrity,and Fecal Flora and Organic Acids in Hepatic Surgery With or Without Cirrhosis

Abstract

Background: The aim of this study was to assess the effect of preoperative and postoperative synbiotic treatment in hepatectomy patients with or without liver cirrhosis. Methods: Sixty-one patients with hepatic cancer were assigned randomly to receive either oral synbiotics that consisted of Bifidobacterium, Lactobacillus, and galactooligosaccharides or no synbiotics (control) preoperatively for 14 days and postoperatively for 11 days. Infectious complications, intestinal mucosal integrity as measured by serum diamine oxidase (DAO) activity, and fecal flora and organic acid concentrations were compared between synbiotic treatment (n = 32) and control (n = 29) groups. Results: Fecal flora culture and organic acid concentrations were changed after hepatectomy in both groups. The postsurgery decrease in DAO activity was less profound in the synbiotic-treated group (P < .01) and was correlated negatively with serum interleukin 6 and C-reactive protein concentrations (P < .001). Infectious complications occurred in 5 (17.2%) patients in the control group and no patients in the synbiotic-treated group (P < .05). Conclusion: Perioperative synbiotic treatment attenuated the decrease in intestinal integrity and reduced the rate of infectious complications in patients with or without liver cirrhosis who underwent hepatic surgery.

Keywords

synbiotics hepatectomy liver cirrhosis diamine oxidase activity infectious complication fecal flora

Get full access to this article

View all access options for this article.

References

Riordan

Williams

. The intestinal flora and bacterial infection in cirrhosis. J Hepatol. 2006;45:744-757.

Yoneyama

Miyagishi

Kikuchi

Shibata

Mitamura

. Risk factors for infections in cirrhotic patients with and without hepatocellular carcinoma. J Gastroenterol. 2002;37:1028-1034.

Fernández

Navasa

Gómez

. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology. 2002;35:140-148.

Gunnarsdottir

Sadik

Shev

. Small intestinal motility disturbances and bacterial overgrowth in patients with liver cirrhosis and portal hypertension. Am J Gastroenterol. 2003;98:1362-1370.

Yeh

. Bacterial translocation after cirrhotic liver resection: a clinical investigation of 181 patients. J Surg Res. 2003;111:209-214.

Lilly

Stillwell

. Probiotics: growth-promoting factors produced by microorganisms. Science. 1965;147:747-748.

Fuller

. Probiotics in human medicine. Gut. 1991;32:439-442.

Collins

Gibson

. Probiotics, prebiotics, and synbiotics: approaches for modulating the microbial ecology of the gut. Am J Clin Nutr. 1999;69:1052S-1057S.

Liu

Duan

Bengmark

Kurtovic

Riordan

. Synbiotic modulation of gut flora: effect on minimal encephalopathy in patients with cirrhosis. Hepatology. 2004;39:1441-1449.

10.

Loguercio

Federico

Tuccillo

. Beneficial effects of a probiotic VSL#3 on parameters of liver dysfunction in chronic liver diseases. J Clin Gastroenterol. 2005;39:540-543.

11.

Rayes

Seehofer

Hansen

. Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients. Transplantation. 2002;74:123-127.

12.

Rayes

Hansen

Seehofer

. Early enteral supply of fiber and lactobacillus versus conventional nutrition: a controlled trial in patients with major abdominal surgery. Nutrition. 2002;18:609-615.

13.

Olah

Belagyi

Issekutz

Gamal

Bengmark

. Randomized clinical trial of specific lactobacillus and fibre supplement to early enteral nutrition in patients with acute pancreatitis. Br J Surg. 2002;89:1103-1107.

14.

Rayes

Seehofer

Theruvath

. Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation—a randomized, double-blind trial. Am J Transplant. 2005;5:125-130.

15.

Kanazawa

Nagino

Kamiya

. Synbiotics reduce postoperative infectious complications: a randomized controlled trial in biliary cancer patients undergoing hepatectomy. Langenbecks Arch Surg. 2005;390:104-113.

16.

Woodcock

McNaught

Morgan

Gregg

MacFie

. An investigation into the effect of a probiotic on gut immune function in surgical patients. Clin Nutr. 2004;23:1069-1073.

17.

Sugawara

Nagino

Nishio

. Perioperative synbiotic treatment to prevent postoperative infectious complications in biliary cancer surgery: a randomized controlled trial. Ann Surg. 2006;244:706-714.

18.

Anderson

McNaught

Jain

MacFie

. Randomized clinical trial of synbiotic therapy in elective surgical patients. Gut. 2004;53:241-245.

19.

Schneider

Le Gall

Girard-Pipau

. Total artificial nutrition is associated with major changes in the fecal flora. Eur J Nutr. 2000;39:248-255.

20.

Matsuzaki

Takagi

Ikemura

Matsuguchi

Yokokura

. Intestinal microflora: probiotics and autoimmunity. J Nutr. 2007;137(3 suppl 2):798S-802S.

21.

Shioiri

Yahagi

Nakayama

. The effects of a synbiotic fermented milk beverage containing Lactobacillus casei strain Shirota and transgalactosylated oligosaccharides on defecation frequency, intestinal microflora, organic acid concentrations, and putrefactive metabolites of sub-optimal health state volunteers: a randomized placebo-controlled cross-over study. Biosci Microflora. 2006;25:137-146.

22.

Takagi

Nakao

Ogura

Nabeshima

Kunii

. Sensitive colorimetric assay of serum diamine oxidase. Clin Chim Acta. 1994;226:67-75.

23.

Alexander

Bovce

Babcock

. The process of microbial translocation. Ann Surg. 1990;212:496-512.

24.

Bone

Balk

Cerra

. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine Chest. 1992;101:1644-1655.

25.

Liver Cancer Study Group of Japan. General Rules for the Clinical and Pathological Study of Primary Liver Cancer. 2nd ed. Tokyo, Japan: Kanehara; 2003.

26.

Kiwaki

Sato

. Antimicrobial susceptibility of Bifidobacterium breve strains and genetic analysis of streptomycin resistance of probiotics B. breve strain Yakult. Int J Food Microbiol. 2009;134:211-215.

27.

Rombeau

Reilly

Rolandelli

. Short-chain fatty acids and intestinal surgery: rationale and clinical implication. In: Cummings

Rombeau

Sakata

, eds. Physiology and Clinical Aspects of Short-Chain Fatty Acids. New York, NY: Cambridge University Press; 1995:401-425.

28.

Ohata

Usami

Miyoshi

. Short-chain fatty acids alter tight junction permeability in intestinal monolayer cells via lipoxygenase activation. Nutrition. 2005;21:838-847.

29.

Miyoshi

Usami

Ohata

. Short-chain fatty acids and trichostatin A alter tight junction permeability in human umbilical vein endothelial cells. Nutrition. 2008;24:1189-1198.

30.

Usami

Kishimoto

Ohata

. Butyrate and trichostatin A attenuate nuclear factor kappaB activation and tumor necrosis factor alpha secretion and increase prostaglandin E2 secretion in human peripheral blood mononuclear cells. Nutr Res. 2008;28:321-328.

31.

Aoyama

Kotani

Usami

. Butyrate and propionate induced activated or non-activated neutrophil apoptosis via HDAC inhibitor activity but without activating GPR-41/GPR-43 pathways. Nutrition. 2010;26:653-661.

32.

Tedelind

Westberg

Kjerrulf

Vidal

. Anti-inflammatory properties of the short-chain fatty acids acetate and propionate: a study with relevance to inflammatory bowel disease. World J Gastroenterol. 2007;28:2826-2832.

33.

Stadlbauer

Mookerjec

Hodges

Wright

Davies

Jalan

. Effect of probiotic treatment on deranged neutrophil function and cytokine responses in patients with compensated alcoholic cirrhosis. J Hepatol. 2008;48:945-951.

34.

Alander

Satokari

Korpela

. Persistence of colonization of human colonic mucosa by a probiotics strain, Lactobacillus rhamnosus GG, after oral consumption. Appl Environ Microbiol. 1999;65:351-354.

35.

Ishikawa

Takayama

Matsumoto

. Effects of β 1-4 linked galactooligosaccharides on human fecal microflora [in Japanese]. Bifidus. 1995;9:5-18.

36.

Besselink

MGH

von Santvoort

Buskens

. Probiotic prophylaxis in predicted severe acute panctreatitis: a randomised, double-blind, placebo-controlled trial. Lancet. 2008;371:651-659.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.16 MB